Cargando…
Serum Metabolic Profiling in a Mouse Model of Adriamycin-Induced Focal Segmental Glomerulosclerosis
Autores principales: | Lyu, Li, Wang, Cai-Li, Li, Zeng-Yan, Shi, Ying-Jin, Zhang, Yan-Hui, Mi, Yan, Hu, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247589/ https://www.ncbi.nlm.nih.gov/pubmed/30425202 http://dx.doi.org/10.4103/0366-6999.245266 |
Ejemplares similares
-
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
por: Zhuang, Qiyuan, et al.
Publicado: (2020) -
Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine
por: Lim, Cho A, et al.
Publicado: (2022) -
Serum microRNAs levels in primary focal segmental glomerulosclerosis
por: Cai, Xiaoyi, et al.
Publicado: (2013) -
Complement activation profile of patients with primary focal segmental glomerulosclerosis
por: Huang, Jing, et al.
Publicado: (2020) -
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007)